Marathon Digital Holdings Inc vs Natera Inc. Common Stock — how do they compare? Marathon Digital Holdings Inc trades at $8.09 (market cap $3.52B), while Natera Inc. Common Stock trades at $394 (market cap $57.03B). The key difference: Natera Inc. Common Stock is far larger — about 16.2× Marathon Digital Holdings Inc's market cap, and Natera Inc. Common Stock is trading nearer its 52-week high, Marathon Digital Holdings Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Marathon Digital Holdings Inc for 22 Days and Natera Inc. Common Stock for 0 Days on average.
| MARA | NTRA | |
|---|---|---|
Market Cap | $3.52B | $57.03B |
Volume | 36,018,511 | 1,131,157 |
Sector | Financials | Health |
52-Week High | $22.84 | $425.64 |
52-Week Low | $6.73 | $179.42 |
Typical Hold Time | 22 Days | 0 Days |
Enterprise Value | $5.56B | $56.18B |
Signals from Pluang's Aura AI — not financial advice
Marathon Digital Holdings (MARA) trades at $9.11, down 3.5% on the day, reflecting ongoing volatility amid mixed technical signals. The stock shows bearish momentum in moving averages but bullish oscillators, with key resistance at $10. Fundamentally, the company reported significant losses with a net income margin of -429.71% in 2026, though valuation ratios appear attractive with P/E of 3.37. Recent news highlights continued analyst coverage and Bitcoin-related sector movements influencing stock performance.
MARA presents a high-risk opportunity with analyst consensus price target of $13 offering 43% upside potential, balanced by 45% buy and 45% hold ratings. However, persistent negative earnings, cash flow challenges, and Bitcoin market dependency create substantial risk. Investors must weigh the discounted valuation against the company's inability to achieve profitability despite revenue generation.
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Marathon Digital Holdings, Inc. is one of the largest publicly traded Bitcoin mining companies in North America. The company focuses on building and operating large-scale, cost-efficient Bitcoin mining facilities. Marathon's strategy centers on increasing its mining hash rate and using sustainable energy sources to expand its Bitcoin production. The company's performance is closely tied to the price of Bitcoin and the overall health of the digital asset mining industry.
Read more on MARA →Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →